Hemoperfusion Cartridge Market Size, Share, Growth, and Industry Growth by Type (Charcoal Hemoperfusion and Certain Resins Hemoperfusion), By Application (Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy, and Others), Regional Forecast To 2031

Updated On: 08 April 2024

Hemoperfusion Cartridge Market REPORT OVERVIEW

• 
• Request a Free sample to learn more about this report

The global hemoperfusion cartridge market size was USD 669.9 million in 2022 and is projected to touch USD 2373.88 million by 2031, at a CAGR of 15.1% during the forecast period.

Hemoperfusion cartridge is made for extracorporeal blood purification treatments for severely ill patients. Such patients who have suffered from cytokine storm such as trauma, severe inflammation, cardiac surgery, sepsis, and pancreatitis. Hemoperfusion is a method that filters toxins from blood from outside of the body. Raw materials used for the process are polycarbonate, membrane materials, polypropylene, and activated charcoal. The blood is circulated through a cartridge which has solid sorbent material. Solute removal and blood purification are gained by absorbing the molecules onto sorbent particles.  

The growing demand for hemoperfusion cartridge is due to increasing demand from the healthcare sector for removal of toxins and poison from blood. New coating technology and developments in production have increased the interest in hemoperfusion which is expected to drive the product demand. Increasing advancements and technologies for blood purification equipment is also expected to pose an opportunity for the market. Increasing autoimmune diseases amongst the population is anticipated to drive the market growth. Emergencies regarding removal of blood purification and removal of wastes from patients that are suffering from severe illness are projected to support the market during the forecast period. Growing applications of blood purification technology in treating COVID-19 patients and cardiac surgery patients

COVID-19 Impact: Use of the Product to Treat COVID-19 to Support Market Growth

The effects of the COVID-19 pandemic are already being felt on a global level, the global hemoperfusion cartridge market was significantly influenced. The outbreak of COVID-19 had a negative impact on several markets. Various countries went into lockdown. With sudden pandemic, all kinds of businesses observed disruptions. With many restrictions in the pandemic, different types of markets were negatively impacted. The demand for hemoperfusion cartridge during the pandemic was present due to continuous R&D activities that continued to explore the benefits of the hemoperfusion equipment. Manufacturers provided the equipment for blood purification that can be used to treat COVID-19 patients. With restrictions lifting up, the market is expected to have traction that can help in the growth of the market.

LATEST TRENDS

"Advancements and Technologies to Improve Market Progress"

The global hemoperfusion cartridge market growth is anticipated to boost owing to development and integration of various technologies. There have been various technologies that have innovated and given rise to new hemoperfusion equipment and machines. There have been advancements and progress in pathophysiology and bio separation techniques. New HP devices have improved their biocompatibility during the years. Applications of blood purification technology in treating COVID-19 patients and cardiac surgery patients. Such increasing and advanced applications of the product in the medical industry is anticipated to drive the market growth.     

Hemoperfusion Cartridge Market SEGMENTATION

• 
• Request a Free sample to learn more about this report

• By Type

According to type; the market is divided into charcoal hemoperfusion and certain resins hemoperfusion

• By Application

Based on the application; the market is divided into overdose, specific intoxications, certain autoimmune diseases, hepatic encephalopathy, and others.

Autoimmune diseases are the leading part of the application segment.

DRIVING FACTORS

"Increasing Cases of Blood Purification to Strengthen Market Growth"

The global hemoperfusion cartridge market growth is anticipated to boost owing to growing cases of blood purification cases. One of the primary applications is removal of toxins from blood and purification of blood. Increasing cases of blood purification due to growing cases in autoimmune and metabolic health disorders. The improvement made in bio separation techniques such as filtration, absorption, and dialysis are some of the key factors that can impel the use of blood purification equipment. Such medical applications of the product are anticipated to drive the market growth.     

"Treatment of COVID-19 to Drive Product Demand"

Increasing demand for hemoper                fusion cartridge is growing due to its medical applications in treating COVID-19 positive patients. The treatment of the equipment is also on the rise during the pandemic. It is used to mitigate excessive inflammation and due to its efficacy. This new application is also anticipated to increase the product demand. Such growing demand due to its various medical applications to treat other diseases is anticipated to fuel the demand in the hemoperfusion cartridge market.   

RESTRAINING FACTORS

Health Hazards of the Product to Hamper Market Growth

There are a number of factors that can push the growth of the hemoperfusion cartridge market. Restraining factors such as leucopenia, thrombocytopenia, reduction in clotting factors, and hypoglycemia are some of the complications associated with the process. Risk of bleeding is also high and reduction of platelets are also some of the restraining factors. Such factors are anticipated to restrict and limit the market growth.   

Hemoperfusion Cartridge Market REGIONAL INSIGHTS

• 
• Request a Free sample to learn more about this report

"North America to Lead Market Due to Demand for Hemoperfusion Equipment  "

North America holds the largest part of the global hemoperfusion cartridge market share due to increasing demand for hemoperfusion equipment. The region also has a robust demand for hemodialysis and blood purification techniques. The surge in the market growth is also due to increasing investments and technological advancements to support the numerous applications. Increasing R&D activities and studies is also expected to increase the market share for the region.

Asia Pacific is also anticipated to have considerable market growth owing to lucrative opportunities by market players. The demand is also attributed to growing lifestyle conditions that could lead to autoimmune diseases, chronic glomerulonephritis, hypertension, and diabetes. Increasing R&D activities by the companies present in the region is anticipated to drive product demand. Presence of majority of market players in the region is also expected to drive market growth.    

KEY INDUSTRY PLAYER

"Market Players to Boost Market Growth"

The report delivers information about the list of market players and their operations in the industry. The information is collected and reported with proper research, technological developments, acquisitions, mergers, expanding production lines, and partnerships. Other aspects examined for this market include companies producing and introducing new products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

List of Market Players Profiled

• Baihe Medical (China)
• Asahi Kasei Corporation (Japan)
• Jafron Biomedical (China)
• Kaneka Pharma (Japan)
• Kangbeir Medical Device (China)
• Toray Medical (Japan)
• Biosun Corporation (U.S.)
• CytoSorbents Corporation (U.S.)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.